Defining the CSF Cytokine and Chemokine Signature of Neurosarcoidosis (S38.009)
Georgios Mangioris(Mayo Clinic), Αναστασία Ζεκερίδου(Mayo Clinic), Ivana Vodopivec(Roche (Switzerland)), Divyanshu Dubey(Mayo Clinic in Arizona), A. Sebastian López‐Chiriboga, Eoin P. Flanagan(Mayo Clinic in Arizona), W. Oliver Tobin(Mayo Clinic), John R. Mills(Mayo Clinic), Sean J. Pittock(Mayo Clinic), Allen J. Aksamit, Michel B. Tolédano(Mayo Clinic), Andrew McKeon(Mayo Clinic), Binxia Yang(Mayo Clinic in Arizona)
Cited by 1
Related Papers
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
|The Lancet|2004|3.2k
Revised diagnostic criteria for neuromyelitis optica
|Neurology|2006|2.6k
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
|The Journal of Experimental Medicine|2005|2.3k
The spectrum of neuromyelitis optica
|The Lancet Neurology|2007|2.2k
Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis
|Annals of Neurology|2018|758